Western drugmakers and regulators are under mounting pressure to ensure the safety of clinical trials conducted in developing countries after reports of death and complications in participants. Some experts are concerned about possible violations of clinical-testing rules, while others worry that companies may be taking advantage of individuals desperate to join studies. Drugmakers said they follow the rules when conducting trials abroad, including securing government authorization and routinely inspecting sites.

Related Summaries